Mid-Cap Biotech Viking Therapeutics Could Emerge as a Potential Challenger to Eli Lilly and Novo Nordisk Life Science
Can Zumilokibart Become the Next Megablockbuster? Inside AbbVie’s $10.9 Billion Bet on Apogee Life Science
AI Rewrites Drug Discovery: Eli Lilly and Twist Bioscience Chart Two Distinct Industrialization Paths Life Science, Technology
Why CRISPR Therapeutics Stock Is Stuck Despite Boasting the World’s First Approved CRISPR Therapy Life Science
S&P 500 Flashes Rare Bullish Signal: After 19% Two-Month Surge, History Says 28% Gain Next Consumer Goods, Financial Service, Life Science, Technology
Trulieve Becomes First U.S. Cannabis Operator to List on NYSE in Historic Industry Milestone Cannabis
Intuitive Surgical Draws Big Citadel Bet as Ken Griffin Trims Nvidia, Amazon Stakes Life Science, Technology
Healthcare Expenditures Continue to Grow, Three Leading Stocks Lead the 2026 Investment Race Life Science
